Mount Sinai now joins this collaborative network, expanding its reach and capabilities at a critical moment for the field. “We are thrilled to have Mount Sinai join the Colton Consortium, bringing expertise in autoimmunity and immune profiling that will complement existing work at the other four Colton centers,” says Colton Consortium Director John Wherry, PhD. The new Center extends these capabilities to autoimmune disease research, expanding the Consortium's collective ability to identify disease earlier, develop precision therapies, and improve patient outcomes. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. -------------------------------------------------------* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.